Vijay Kumar
Stock Analyst at Evercore ISI Group
(3.28)
# 1,035
Out of 5,132 analysts
287
Total ratings
50.29%
Success rate
1.4%
Average return
Main Sectors:
Stocks Rated by Vijay Kumar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| USB U.S. Bancorp | Maintains: In-Line | $60 → $65 | $57.69 | +12.67% | 8 | Feb 5, 2026 | |
| GEHC GE HealthCare Technologies | Maintains: Outperform | $95 → $98 | $80.34 | +21.98% | 6 | Feb 5, 2026 | |
| BSX Boston Scientific | Maintains: Outperform | $112 → $96 | $74.73 | +28.46% | 8 | Feb 5, 2026 | |
| AZTA Azenta | Maintains: Outperform | $50 → $45 | $28.62 | +57.23% | 10 | Feb 5, 2026 | |
| TWST Twist Bioscience | Maintains: Outperform | $42 → $52 | $49.11 | +5.88% | 7 | Feb 3, 2026 | |
| RVTY Revvity | Maintains: Outperform | $112 → $118 | $96.03 | +22.88% | 4 | Feb 3, 2026 | |
| ISRG Intuitive Surgical | Maintains: In-Line | $580 → $550 | $485.84 | +13.21% | 15 | Jan 23, 2026 | |
| ABT Abbott Laboratories | Maintains: Outperform | $144 → $138 | $112.68 | +22.47% | 18 | Jan 23, 2026 | |
| JBHT J.B. Hunt Transport Services | Maintains: Outperform | $168 → $223 | $221.76 | +0.56% | 9 | Jan 13, 2026 | |
| HOLX Hologic | Downgrades: In-Line | $79 → $78 | $75.06 | +3.92% | 17 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: In-Line | $105 | $103.24 | +1.70% | 8 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: In-Line | $18 | $17.03 | +5.70% | 12 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: In-Line | $14 → $12 | $9.20 | +30.43% | 13 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $94 → $120 | $96.45 | +24.42% | 15 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $194 → $210 | $144.30 | +45.53% | 3 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $155 → $160 | $125.81 | +27.18% | 8 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $410 → $405 | $366.05 | +10.64% | 13 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $132 → $142 | $116.81 | +21.56% | 9 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $88 → $92 | $75.87 | +21.26% | 15 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $525 → $590 | $504.82 | +16.87% | 13 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $300 → $285 | $339.30 | -16.00% | 2 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $1,275 → $1,400 | $1,360.95 | +2.87% | 12 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $226 → $245 | $212.58 | +15.25% | 4 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $33 → $31 | $19.79 | +56.64% | 8 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $33 → $40 | $20.62 | +93.99% | 2 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $103 → $106 | $99.49 | +6.54% | 5 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $48 → $46 | $21.77 | +111.30% | 4 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $3 | $2.76 | +8.89% | 6 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $18 → $30 | $10.99 | +172.98% | 11 | Dec 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $335 → $355 | $323.37 | +9.78% | 8 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $120 → $160 | $90.17 | +77.45% | 7 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $286 → $290 | $175.89 | +64.88% | 6 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $7 | $1.11 | +530.63% | 1 | May 31, 2022 |
U.S. Bancorp
Feb 5, 2026
Maintains: In-Line
Price Target: $60 → $65
Current: $57.69
Upside: +12.67%
GE HealthCare Technologies
Feb 5, 2026
Maintains: Outperform
Price Target: $95 → $98
Current: $80.34
Upside: +21.98%
Boston Scientific
Feb 5, 2026
Maintains: Outperform
Price Target: $112 → $96
Current: $74.73
Upside: +28.46%
Azenta
Feb 5, 2026
Maintains: Outperform
Price Target: $50 → $45
Current: $28.62
Upside: +57.23%
Twist Bioscience
Feb 3, 2026
Maintains: Outperform
Price Target: $42 → $52
Current: $49.11
Upside: +5.88%
Revvity
Feb 3, 2026
Maintains: Outperform
Price Target: $112 → $118
Current: $96.03
Upside: +22.88%
Intuitive Surgical
Jan 23, 2026
Maintains: In-Line
Price Target: $580 → $550
Current: $485.84
Upside: +13.21%
Abbott Laboratories
Jan 23, 2026
Maintains: Outperform
Price Target: $144 → $138
Current: $112.68
Upside: +22.47%
J.B. Hunt Transport Services
Jan 13, 2026
Maintains: Outperform
Price Target: $168 → $223
Current: $221.76
Upside: +0.56%
Hologic
Jan 5, 2026
Downgrades: In-Line
Price Target: $79 → $78
Current: $75.06
Upside: +3.92%
Jan 5, 2026
Downgrades: In-Line
Price Target: $105
Current: $103.24
Upside: +1.70%
Jan 5, 2026
Downgrades: In-Line
Price Target: $18
Current: $17.03
Upside: +5.70%
Jan 5, 2026
Downgrades: In-Line
Price Target: $14 → $12
Current: $9.20
Upside: +30.43%
Jan 5, 2026
Upgrades: Outperform
Price Target: $94 → $120
Current: $96.45
Upside: +24.42%
Jan 5, 2026
Upgrades: Outperform
Price Target: $194 → $210
Current: $144.30
Upside: +45.53%
Jan 5, 2026
Upgrades: Outperform
Price Target: $155 → $160
Current: $125.81
Upside: +27.18%
Oct 31, 2025
Maintains: Outperform
Price Target: $410 → $405
Current: $366.05
Upside: +10.64%
Oct 31, 2025
Maintains: Outperform
Price Target: $132 → $142
Current: $116.81
Upside: +21.56%
Oct 31, 2025
Maintains: Outperform
Price Target: $88 → $92
Current: $75.87
Upside: +21.26%
Oct 7, 2025
Maintains: Outperform
Price Target: $525 → $590
Current: $504.82
Upside: +16.87%
Oct 7, 2025
Maintains: Outperform
Price Target: $300 → $285
Current: $339.30
Upside: -16.00%
Oct 7, 2025
Maintains: Outperform
Price Target: $1,275 → $1,400
Current: $1,360.95
Upside: +2.87%
Oct 7, 2025
Maintains: Outperform
Price Target: $226 → $245
Current: $212.58
Upside: +15.25%
Oct 7, 2025
Maintains: Outperform
Price Target: $33 → $31
Current: $19.79
Upside: +56.64%
Aug 13, 2025
Maintains: Outperform
Price Target: $33 → $40
Current: $20.62
Upside: +93.99%
Jul 8, 2025
Maintains: Outperform
Price Target: $103 → $106
Current: $99.49
Upside: +6.54%
Jul 8, 2025
Maintains: Outperform
Price Target: $48 → $46
Current: $21.77
Upside: +111.30%
May 19, 2025
Maintains: In-Line
Price Target: $3
Current: $2.76
Upside: +8.89%
Dec 2, 2024
Upgrades: Outperform
Price Target: $18 → $30
Current: $10.99
Upside: +172.98%
Oct 1, 2024
Maintains: In-Line
Price Target: $335 → $355
Current: $323.37
Upside: +9.78%
Oct 1, 2024
Maintains: Outperform
Price Target: $120 → $160
Current: $90.17
Upside: +77.45%
Oct 1, 2024
Maintains: Outperform
Price Target: $286 → $290
Current: $175.89
Upside: +64.88%
May 31, 2022
Initiates: Outperform
Price Target: $7
Current: $1.11
Upside: +530.63%